The FDA is set to approve the Alzheimer’s treatment lecanemab.
![The FDA is set to approve the Alzheimer’s treatment lecanemab.](https://www.marketwiseanalytics.com/wp-content/uploads/2023/07/images-1-770x450.jpg)
Summary: Specialists are planning to oversee lecanemab, a promising new Alzheimer’s sickness therapy approaching FDA endorsement. By removing amyloid proteins from the brain and thereby…